Kornitzer Capital Management Inc. KS Has $3.41 Million Position in Celsius Holdings, Inc. (NASDAQ:CELH)

Kornitzer Capital Management Inc. KS raised its stake in Celsius Holdings, Inc. (NASDAQ:CELH - Free Report) by 200.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 62,505 shares of the company's stock after acquiring an additional 41,670 shares during the period. Kornitzer Capital Management Inc. KS's holdings in Celsius were worth $3,408,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Capital International Investors bought a new stake in Celsius during the 1st quarter worth approximately $93,034,000. Allspring Global Investments Holdings LLC grew its position in Celsius by 633.9% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,422,367 shares of the company's stock worth $77,547,000 after acquiring an additional 1,228,560 shares during the last quarter. Vanguard Group Inc. grew its position in Celsius by 18.7% during the 3rd quarter. Vanguard Group Inc. now owns 4,846,599 shares of the company's stock worth $831,676,000 after acquiring an additional 762,087 shares during the last quarter. Alyeska Investment Group L.P. acquired a new position in Celsius during the 1st quarter worth about $45,022,000. Finally, Braun Stacey Associates Inc. lifted its position in Celsius by 192.5% during the 3rd quarter. Braun Stacey Associates Inc. now owns 634,863 shares of the company's stock worth $108,942,000 after buying an additional 417,825 shares in the last quarter. 60.95% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Celsius

In other Celsius news, major shareholder Dean Desantis sold 100,000 shares of the business's stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $95.75, for a total value of $9,575,000.00. Following the completion of the transaction, the insider now directly owns 219,257 shares of the company's stock, valued at $20,993,857.75. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other Celsius news, CFO Jarrod Langhans sold 4,079 shares of Celsius stock in a transaction that occurred on Friday, April 19th. The shares were sold at an average price of $69.42, for a total value of $283,164.18. Following the transaction, the chief financial officer now owns 83,670 shares of the company's stock, valued at $5,808,371.40. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, major shareholder Dean Desantis sold 100,000 shares of Celsius stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $95.75, for a total transaction of $9,575,000.00. Following the completion of the transaction, the insider now directly owns 219,257 shares in the company, valued at approximately $20,993,857.75. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,038,400 shares of company stock valued at $60,947,637. Company insiders own 2.70% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on CELH shares. UBS Group upped their price target on shares of Celsius from $73.00 to $99.00 and gave the stock a "buy" rating in a research report on Friday, March 1st. Jefferies Financial Group boosted their price objective on shares of Celsius from $98.00 to $105.00 and gave the stock a "buy" rating in a research report on Monday, March 18th. Wedbush boosted their price objective on shares of Celsius from $75.00 to $90.00 and gave the stock an "outperform" rating in a research report on Monday, March 4th. Maxim Group boosted their price objective on shares of Celsius from $100.00 to $110.00 and gave the stock a "buy" rating in a research report on Monday, April 1st. Finally, Piper Sandler lifted their price objective on Celsius from $76.00 to $90.00 and gave the stock an "overweight" rating in a research report on Friday, March 1st. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, Celsius has an average rating of "Moderate Buy" and a consensus target price of $85.10.

Celsius Stock Performance

NASDAQ:CELH traded down $1.13 during trading hours on Friday, hitting $68.84. The stock had a trading volume of 3,574,788 shares, compared to its average volume of 3,411,994. Celsius Holdings, Inc. has a one year low of $29.42 and a one year high of $99.62. The company has a market cap of $15.90 billion, a price-to-earnings ratio of 89.02, a P/E/G ratio of 2.01 and a beta of 1.86. The business's 50 day moving average is $78.80 and its 200-day moving average is $64.30.

Celsius (NASDAQ:CELH - Get Free Report) last issued its earnings results on Thursday, February 29th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.16 by $0.01. Celsius had a net margin of 17.21% and a return on equity of 131.58%. The firm had revenue of $347.44 million during the quarter, compared to the consensus estimate of $326.77 million. During the same quarter in the prior year, the firm earned $0.01 earnings per share. The business's quarterly revenue was up 95.2% on a year-over-year basis. On average, sell-side analysts anticipate that Celsius Holdings, Inc. will post 1.09 EPS for the current fiscal year.

Celsius Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.